DermaGen develops peptide therapeutics for topical use based on novel and proprietary antimicrobial peptides (AMPs). We intend to be a leading R&D company in this area with the aim of offering innovative and profitable licensing opportunities to selected pharmaceutical companies with significant market potential. DermaGen focuses on R&D to provide new and patented products initially for dermatological indications.
|
|
|
|
|
1-10 employees
View all DermaGen AB employees
|
|
|
Pharmaceutical Manufacturing
|
|
|
Scheelevägen 22, Lund, SE
|
|
|
2004
|
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.